Douglas Clark, Executive Director of the Patented Medicine Prices Review Board (PMPRB), has announced that he will be stepping down from that position after almost a decade at the PMPRB.

"In his nine years at the Board, Doug has been an outstanding leader, creating and sustaining a high-performance leadership team and developing an internal culture which is widely admired across the government. At the behest of the Board, he succeeded in testing the limits of the PMPRB's mandate, in the boldest tradition of the federal public service, opening the path for future Boards to implement predictable processes with confidence and clarity. The results he delivered on preventing excessive pricing of pharmaceuticals in Canada are having a deep and lasting impact on the sustainability of the entire Canadian health care system. On behalf of the Board, I offer our thanks for his years of dedication and commitment, and heartfelt wish that he, and his family, find success wherever their future path may take them."

- Thomas J. Digby, Chairperson, PMPRB

"It has been the honour of my professional life to serve as Executive Director of the PMPRB. People may come and go but the commitment of staff at the PMPRB to the very highest ideals of public service is unwavering and will endure. I would like to thank the current and former Chairpersons of the Board for their steadfast support and especially my outstanding senior management team, who I consider the very best of colleagues but also dear friends."

- Douglas Clark, Executive Director, PMPRB

PMPRB Media Relations
PMPRB.MediaCentre-CentreMedias.CEPMB@pmprb-cepmb.gc.ca
Follow us on Twitter: @PMPRB_CEPMB